A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma
Open Access
- 15 October 2000
- Vol. 89 (8) , 1714-1719
- https://doi.org/10.1002/1097-0142(20001015)89:8<1714::aid-cncr10>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer A multicenter phase II studyLung Cancer, 2000
- Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Cigarettes, Sex, and Lung AdenocarcinomaJNCI Journal of the National Cancer Institute, 1997
- Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancerAnnals of Oncology, 1997
- Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.Journal of Clinical Oncology, 1997
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Clinical and preclinical activity of 2′,2′- difluorodeoxycytidine (gemcitabine)Cancer Treatment Reviews, 1993
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992